MEI Pharma Inc. has announced a private placement agreement to raise approximately $100 million through the sale of 29,239,767 shares of common stock at $3.42 per share. The proceeds will be dedicated to implementing a Litecoin Treasury Strategy, marking MEI Pharma as the first publicly traded company on a national exchange to hold Litecoin. Charlie Lee, the founder of Litecoin and a lead investor in the transaction, will join MEI's Board of Directors upon closing, replacing current member Taheer Datoo. GSR will oversee the company's digital asset and treasury management. Titan Partners Group is acting as the sole placement agent for this transaction, which is expected to close around July 22, 2025, pending customary closing conditions.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。